Literature DB >> 12397516

[Do psychological factors change in patients with spasmodic dysphonia after injections with botulinum-toxin?].

C Kiese-Himmel1, M Reeh, H Liebeck, P Zwirner.   

Abstract

OBJECTIVE: A pre-/posttherapeutic comparative study was carried out to investigate possible associations of voice symptoms, selected psychological factors and their changing. SAMPLE: A total of 11 patients with spasmodic dysphonia (adductor-type) subjected to botulinum-toxin-therapy. Patients had received treatment without any complications for at least 2 years. During that period of time, they received a minimum of 3 and a maximum of 9 injections (mean: 6).
METHODS: Psychosocial data were measured before and after treatment using standardized psychological methods. The time span between measurements ranged from 1;8 to 4;6 years, with an average of 2;1 years.
RESULTS: On average, no somatic disorder, no clinically meaningful states of anxiety or pathological manifestations of personality traits could be detected, neither pre- nor posttherapeutically. The average stress load caused by life-changing-events was unobtrusive. Before treatment, 5 of 11 patients had an affective disorder in terms of a depressed mood. This caused a higher than average mean depressivity score for the group as a whole. It was no longer found posttherapeutically.
CONCLUSION: The depression is interpreted as a psychic reaction. An association between spasmodic voice symptoms and psychosocial genesis could not be proved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12397516     DOI: 10.1055/s-2002-34999

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  3 in total

1.  Therapeutic methods for psychosomatic disorders in oto-rhino-laryngology.

Authors:  Elke Decot
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

Review 2.  [Treatment of laryngeal movement disorders with botulinum toxins: part 1: History and mode of action].

Authors:  C Schwemmle; M Ptok
Journal:  HNO       Date:  2007-05       Impact factor: 1.284

3.  [The dosage of botulinum toxin type B in adductor type spasmodic dysphonia].

Authors:  R Schönweiler; P Zwirner
Journal:  HNO       Date:  2005-02       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.